Home > Insider Trading > Filing (0001237899-12-000086)

Filing Details

Accession Number:: 0001237899-12-000086
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2012-11-26 15:39:36
Reporting Period:: 2012-11-21

Filing Date:: 2012-11-26
Accepted Time:: 2012-11-26 15:39:36
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
872589	Regeneron Pharmaceuticals Inc	REGN	Pharmaceutical Preparations (2834)	133444607

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1391382	J Robert Terifay	777 Old Saw Mill River Road Tarrytown NY 10591	Svp Commercial	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2012-11-21	20,000	$16.80	29,372	No	4	M	Direct
Common Stock	Disposition	2012-11-21	1,932	$173.83	27,440	No	4	F	Direct
Common Stock	Disposition	2012-11-21	8,323	$173.83	19,117	No	4	F	Direct
Common Stock	Disposition	2012-11-23	1,000	$173.90	18,117	No	4	S	Direct
Common Stock	Disposition	2012-11-23	6,700	$174.33	11,417	No	4	S	Direct
Common Stock	Disposition	2012-11-23	2,045	$175.09	9,372	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	F	Direct
No	4	F	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Non-Qualified Stock Option (right to buy)	Disposition	2012-11-21	20,000	$0.00	20,000	$16.80

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
16,923	2011-12-31	2018-12-17	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	1,531	Indirect	By 401(k) Plan

Footnotes

Represents volume-weighted average price of sales of 1,000 shares of Company stock on November 23, 2012 at prices ranging from $173.90 to $173.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 23, 2012 at each separate price.
Represents volume-weighted average price of sales of 6,700 shares of Company stock on November 23, 2012 at prices ranging from $174.00 to $174.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 23, 2012 at each separate price.
Represents volume-weighted average price of sales of 2,045 shares of Company stock on November 23, 2012 at prices ranging from $175.00 to $175.63. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 23, 2012 at each separate price.
The option became exercisable with respect to all shares underlying the option on December 31, 2011, based upon the satisfaction by the company of certain performance criteria during the period ended December 31, 2011.
Exercisable date, exercise date, exercise price, purchase price, sales price, and/or expiration date is/are not applicable in this case.